Test Price
2,800 AED✅ Home Collection Available
TNNI3 Gene Familial Hypertrophic Cardiomyopathy Type 7 DNA Test in UAE
Executive Summary & Core Metrics
Precision NGS-based TNNI3 gene sequencing with 99.9% diagnostic sensitivity, compliant with DHA clinical guidelines. This advanced genetic test delivers high accuracy for diagnosing familial hypertrophic cardiomyopathy type 7.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (08:00–23:00 daily).
- Clinical Guidance: Post-test telephonic clinical interpretation with a certified genetic counsellor.
- Direct Billing: Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This TNNI3 gene test identifies pathogenic variants in the TNNI3 gene associated with familial hypertrophic cardiomyopathy type 7 (FHC7), enabling early intervention and family screening. The assay employs next-generation sequencing (NGS) with comprehensive coverage of all coding exons and splice junctions, achieving >99.9% analytical sensitivity.
| Feature | Our Test: TNNI3 NGS | Closest Alternative (Sanger/Panel) |
|---|---|---|
| Methodology | Next-Generation Sequencing (NGS) with full gene coverage | Targeted Sanger sequencing or limited gene panel |
| Turnaround Time | 3–4 weeks | 4–6 weeks |
| Variant Detection | High; detects rare and novel variants | Limited to known hotspots |
| Clinical Reporting | ACMG classification, actionable insights | Basic variant list |
Physician Insight & Safety Protocols
“As a physician, I understand that genetic testing for cardiomyopathy can bring anxiety. Rest assured, this test provides critical information for your cardiac health and that of your loved ones. Every result must be interpreted within your full clinical context, and our team will guide you through each step.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Medication Advisory
Medication Warning
Do not discontinue prescribed cardiac medications without explicit consultation with your treating physician. Genetic results do not replace ongoing clinical management.
Exclusion Criteria
- Do not schedule blood collection if you have an active fever or acute infection.
- If you experience syncope (fainting) or severe chest pain, stop the procedure and seek emergency medical care.
- This test is not intended for prenatal diagnosis without specialized counselling; contact us for guidance.
ER Red Flags: Sudden palpitations, chest tightness, or loss of consciousness during or after phlebotomy require immediate emergency attention.
Patient FAQ & Clinical Guidance
1. What variants does the TNNI3 genetic test detect, and how accurate is it?
The TNNI3 NGS test detects pathogenic and likely pathogenic single nucleotide variants, small insertions/deletions, and splice-site mutations with >99.9% analytical sensitivity, ensuring highly accurate familial hypertrophic cardiomyopathy type 7 diagnosis.
2. How should I prepare for the test, and is genetic counselling mandatory?
Preparation requires a detailed clinical history and a mandatory pre‑test genetic counselling session to construct a three‑generation pedigree, ensuring results are interpreted in your family context.
3. How will I receive my results and what support is available post‑test?
You will receive a secure digital report within 3–4 weeks, followed by a telephonic clinical guidance session with a certified genetic counsellor explaining your results and next steps.
UAE Regulatory & Data Privacy Adherence
This service is provided in accordance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is processed within our DHA‑licensed facility under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). Clinical safety and patient consent comply with Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | TNNI3 Gene Familial Hypertrophic Cardiomyopathy Type 7 DNA Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood (3–5 mL in EDTA tube) |
| Methodology Used | Next-Generation Sequencing (NGS) – full gene coverage |
| ICD-10-CM Code | I42.1 |
| LOINC Code | 93929-2 |
| DHA Facility License & Laboratory Address | Facility License 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians